Workshop on Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer

NIH will host a virtual workshop on July 31, 2023, to discuss policies and practices that shape biomedical innovation and promote access to NIH-funded discoveries. Goals will include discussing how NIH, as a research institution, approaches the patenting and licensing of biomedical inventions.  There will also be discussion on the agency’s role in the broader biomedical research enterprise in promoting the application of knowledge to enhance human health.

Webcast

https://videocast.nih.gov/watch=51051

Agenda

Meeting Agenda

Background Information

Information on Providing Comments

We invite members of the public to submit written comments on the topic of this workshop. For those wishing to make written comments, please submit those comments to SciencePolicy@od.nih.gov by August 18, 2023, so that they may be considered prior to preparing the report of this workshop. The comments we receive may be posted to the OSP website without redaction. As such, please do not include any information in your comments that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should also not be included in your comments.

Public Comments

Compiled Set of Written Comments (June 28 – August 19, 2023)

Final Report

Transforming Discoveries Into Products: Maximizing Levers to Catalyze technology Transfer

Slide Presentations

Virtual Listening Session on the NIH Public Access Plan

NIH will host a virtual, public listening session to hear community feedback on the NIH Plan to Enhance Public Access to the Results of NIH-Supported Research (NIH Public Access Plan). The NIH Public Access Plan is currently available for public comment through a Request for Information that NIH issued in February 2023. Written RFI responses on the NIH Public Access Plan will continue to be accepted until April 24, 2023.

Webcast

Agenda

Supplemental Information

Information on How to Provide Oral Comments

Members of the public can sign-up to provide oral comments at the listening session by emailing SciencePolicy@od.nih.gov.  When requesting to provide oral comments, please provide:

  • Name
  • Professional Affiliation (optional/if applicable)
  • Topic(s) of Comment

The RFI for the NIH Public Access Plan lists specific areas of interest for which NIH requests additional feedback: (1) equity in publication opportunities for NIH-supported investigators, (2) equity in access and accessibility of publications, (3) methods for monitoring evolving costs and impacts on affected communities, and (4) considerations to increase findability and transparency of research. Please indicate if your comments involve any of these topics. Comments do not need to be limited to the four topic areas listed in the RFI comment form, but comments should relate to one or more aspects of the NIH Public Access Plan.

Slots for public comments will be provided in the order they are received until all slots have been filled. Requests to provide comments at the listening session must be received no later than April 10, 2023.

Please note that the listening session will be broadcast live, recorded, and posted on the OSP website, and a transcript of the listening session will be prepared. The transcript of the listening session may also be posted to the OSP website without redaction. As such, please do not include any information in your comments that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should also not be included in your comments.

NIH Workshop: Using Public Engagement to Inform the Use of Data in Biomedical Research

The NIH will be holding a workshop on Feb 27 on Using Public Engagement to Inform the Use of Data in Biomedical Research. This workshop will contextualize how public feedback can help inform the use of new types of data (e.g., wearable devices, smart sensors, social media), new types of analyses (e.g., Artificial Intelligence and Machine Learning), and data linkage and aggregation in research. The information discussed will be used to help inform deliberations on the NExTRAC’s charge related to novel types and uses of data.  

The meeting will outline important themes from multiple community conversations NIH has hosted across the country on these topics. It will also feature discussions from ethicists, biomedical researchers, technology engineers and developers, public health experts, and clinician researchers who might utilize novel technologies to generate data. 

Opportunities to raise questions for discussion will be provided for members of the public who attend virtually.

Webcast

https://videocast.nih.gov/watch=49084

Agenda

Meeting Agenda

Materials

(Some background documents have been provided in Spanish, as a community conversation was held in Spanish)

Background Information for the Workshop
Background Information for the Workshop (Spanish)

Community Conversation Summary Feedback
Community Conversation Summary Feedback (Spanish)

Workshop Participant Biographies

National Science Advisory Board for Biosecurity (NSABB) Meeting

Virtual Meeting

Webcast

Agenda

Meeting Minutes

Additional Files

*Note: The NSABB working groups report is a draft, pre-decisional document. The NSABB publicly discussed and endorsed the draft findings and recommendations with minor modifications to the report at the January 27 meeting. The final NSABB report was transmitted to the HHS Secretary and can be found here.

Public Comments

To sign up to make an oral public comment at the meeting, please send an email to SciencePolicy@od.nih.gov at least one business day prior to the meeting date. Once all time slots are filled, only written comments will be accepted.

Any interested person may file written comments by emailing SciencePolicy@od.nih.gov at least one business day prior to the meeting date. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any written comments NIH receives may be posted unredacted to the Office of Science Policy website.

Public Comments